Madison, WI, United States of America

Mark N Shahan

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark N Shahan: Innovator in Cancer Treatment

Introduction

Mark N Shahan is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Shahan's work focuses on delivering toxic agents specifically to cancer cells, enhancing therapeutic efficacy.

Latest Patents

Shahan's latest patents include groundbreaking methods and compositions for the treatment of cancer. One of his notable inventions is directed toward the delivery of toxic agents to pathogenic cells, particularly cancer cells. In some embodiments, the toxic agent is a human ribonuclease or a similar agent that is toxic to cells. Another significant patent involves modified ribonucleases, which relates to conjugates of human ribonucleases and water-soluble polymers. This invention aims to improve the pharmacokinetic profile, stability, and biological activity of the ribonucleases, ultimately aiding in the therapy and prevention of diseases such as cancer.

Career Highlights

Mark N Shahan is associated with Quintessence Biosciences, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to improving patient outcomes.

Collaborations

Shahan collaborates with notable colleagues, including John A Kink and Laura Strong. Their combined expertise contributes to the development of innovative solutions in the field of cancer treatment.

Conclusion

Mark N Shahan stands out as a key inventor in the realm of cancer treatment, with a focus on innovative methods that target cancer cells effectively. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…